Stock Analysis

ASX Growth Companies With High Insider Ownership In October 2024

Published

As the ASX200 flirts with record highs, buoyed by strong performances in the Energy and Materials sectors, investor sentiment remains optimistic across the Australian market. In this environment of positive momentum, growth companies with high insider ownership stand out as potentially compelling opportunities, offering insights into management's confidence and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Australia

NameInsider OwnershipEarnings Growth
Clinuvel Pharmaceuticals (ASX:CUV)10.4%27.4%
Genmin (ASX:GEN)12%117.7%
Catalyst Metals (ASX:CYL)17%49.1%
Hillgrove Resources (ASX:HGO)10.4%71.5%
AVA Risk Group (ASX:AVA)15.7%118.8%
Pointerra (ASX:3DP)20.1%126.4%
Liontown Resources (ASX:LTR)14.7%61%
Acrux (ASX:ACR)17.4%91.6%
Adveritas (ASX:AV1)21.1%144.2%
Plenti Group (ASX:PLT)12.8%106.4%

Click here to see the full list of 99 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Mesoblast (ASX:MSB)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Mesoblast Limited develops regenerative medicine products across Australia, the United States, Singapore, and Switzerland, with a market cap of A$1.59 billion.

Operations: The company generates revenue of $5.90 million from the commercialization of its cell technology platform.

Insider Ownership: 22.2%

Mesoblast faces challenges as it was dropped from the S&P/ASX Emerging Companies Index and reported a net loss of US$87.96 million for FY2024. However, it shows potential with expected revenue growth of 45.8% annually, driven by the FDA's acceptance of its Biologics License Application resubmission for Ryoncil in treating SR-aGVHD. The recent A$72.7 million convertible note issuance supports future growth prospects despite past shareholder dilution and low insider trading activity.

ASX:MSB Ownership Breakdown as at Oct 2024

Nanosonics (ASX:NAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nanosonics Limited is a global infection prevention company with a market capitalization of A$1.11 billion.

Operations: The company's revenue primarily comes from its Healthcare Equipment segment, amounting to A$170.01 million.

Insider Ownership: 15.4%

Nanosonics, despite its recent drop from the S&P/ASX 200 Index, shows strong growth potential with forecasted earnings growth of 23.6% annually, outpacing the Australian market. However, its revenue growth is moderate at 8.7% per year and profit margins have decreased to 7.6%. Trading below fair value by 28.3%, it has seen more insider buying than selling recently but not in substantial volumes, indicating cautious optimism among insiders.

ASX:NAN Earnings and Revenue Growth as at Oct 2024

Pinnacle Investment Management Group (ASX:PNI)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pinnacle Investment Management Group Limited is an investment management company based in Australia with a market capitalization of A$3.79 billion.

Operations: The company's revenue segment consists of Funds Management Operations amounting to A$48.99 million.

Insider Ownership: 31.5%

Pinnacle Investment Management Group is experiencing solid growth, with earnings expected to rise 14.4% annually, surpassing the Australian market's 12.2%. Revenue is forecasted to grow at 13.6% per year, outpacing the broader market's 5.5% growth rate. Recent financial results showed net income of A$90.35 million and sales of A$48.99 million for the year ended June 2024, reflecting steady progress despite no significant insider trading activity in recent months.

ASX:PNI Ownership Breakdown as at Oct 2024

Seize The Opportunity

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com